ARRY
Array Biopharma Inc
ARRY
ARRY
Delisted
ARRY was delisted on the 29th of July, 2019.
169 hedge funds and large institutions have $1B invested in Array Biopharma Inc in 2016 Q3 according to their latest regulatory filings, with 56 funds opening new positions, 46 increasing their positions, 40 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
15% more repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 40
24% less call options, than puts
Call options by funds: $8.53M | Put options by funds: $11.2M
Holders
169
Holding in Top 10
5
Calls
$8.53M
Puts
$11.2M
Top Buyers
| 1 | +$76.6M | |
| 2 | +$29.2M | |
| 3 | +$24.6M | |
| 4 |
O
OrbiMed
New York
|
+$21.6M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$13M |
Top Sellers
| 1 | -$45.3M | |
| 2 | -$16.8M | |
| 3 | -$12.1M | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
-$6.75M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$5.82M |